LONDON, May 2, 2017 /PRNewswire/ -- Highlights
The global transplant diagnostics market is estimated togrow at a CAGR of 7.0% during the forecast period and is expected to be valued at USD 4.36 billion by 2021.
· North American transplant diagnostics market
· Comprehensive information on the
· Detailed insights on the upcoming technologies, R&D activities
· Exhaustive information about new products and services
· R&D investments for innovations in products and technologies
Although the mature markets (North America and Europe) held the largest share of the transplant diagnostics market in 2015; the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period owing to factors such as rising incidence of chronic and infectious diseases, increase in awareness related to transplant diagnostic procedures, and continuously rising healthcare expenditure in the Asia-Pacific region.
Factors such as the growing number of solid organ, tissue, and stem cell transplantation procedures; ongoing technological advancements in the field of genetics; and growing awareness among healthcare professionals about the benefits offered by molecular assay techniques are propelling the growth of the worldwide transplant diagnostics market. In addition, emerging markets (such as China and India) are offering new expansion opportunities for players operating in the market. Geographically, North America is estimated to command the largest share of the global transplant diagnostics market in 2016, followed by Europe. Significant growth potential offered by the North American transplant diagnostics market is attributed to the high adoption of advanced diagnostic technologies among healthcare professionals in the region, increasing prevalence of target diseases, and continuous technological advancements in the field of genomic analysis.The transplant diagnostics market is fairly competitive, with growing number of global and local manufacturers of transplant diagnostic products. Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and F. Hoffman-La Roche Ltd. (Switzerland) were the top three players in the transplant diagnostics market in 2015. Product launches; approvals and product enhancements; agreements, partnerships, and collaborations; geographic expansions are the major strategies adopted by most of the market players to achieve growth in the transplant diagnostics market.Research CoverageApart from the comprehensive geographical and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the transplant diagnostics market and their product portfolios, developments, and strategies. The above-mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.Reasons to Buy the Report: The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.The report provides insights on the following pointers:- Market Penetration: Comprehensive information on the product portfolios of top players in the transplant diagnostics market. The report analyzes the transplant diagnostics market by technology, product and services, application, and end user- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the transplant diagnostics market- Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the transplant diagnostics market- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various transplant diagnostic products across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the transplant diagnostics marketDetailed Segmentation:Transplant Diagnostics Market, by Technology - Molecular Assay- PCR Basedo Real Time PCRo Sequence Specific Primer (SSP) PCRo Sequence Specific Oligonucleotide (Sso) PCRo Other PCR Technologies- Sequencing Basedo Sanger's Sequencingo Next Generation Sequencing (NGS)o Others - Non-molecular AssayTransplant Diagnostics Market, by Products and Services- Instruments- Reagents and Consumables - Software and ServicesTransplant Diagnostics Market, by Application- Research Applications- Diagnostic Applications- Infectious Disease Diagnostics- Histocompatibility Testing- Blood ProfilingTransplant Diagnostics Market, by End User- Commercial Service Providers- Hospitals and Transplant Centers - Research Laboratories and Academic InstitutesTransplant Diagnostics Market, by Region- North America- U.S.- Europe- Asia-Pacific- Rest of the WorldKey Target Audience:- Transplant Diagnostics Product Manufacturing Companies - Healthcare Service Providers (Including Hospitals, and Transplant Centers and Blood Transfusion Centers) - Research and Development (R&D) Companies - Commercial Service Providers- Diagnostic Laboratories- Clinical Research Organizations (CROs) - Research Laboratories and Academic Institutes- Market Research and Consulting FirmsDownload the full report: https://www.reportbuyer.com/product/4606005/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.comFor more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/transplant-diagnostics-market-is-expected-to-be-valued-at-usd-436-billion-by-2021-300450117.html
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All